Impact of the COVID-19 pandemic on admission rates for, and management of, acute coronary syndromes in England by Mafham, MM et al.
Articles
www.thelancet.com   Vol 396   August 8, 2020 381
COVID-19 pandemic and admission rates for and 
management of acute coronary syndromes in England
Marion M Mafham*, Enti Spata*, Raphael Goldacre*, Dominic Gair, Paula Curnow, Mark Bray, Sam Hollings, Chris Roebuck, Chris P Gale, 
Mamas A Mamas, John E Deanfield, Mark A de Belder, Thomas F Luescher, Tom Denwood, Martin J Landray, Jonathan R Emberson, Rory Collins, 
Eva J A Morris†, Barbara Casadei†, Colin Baigent†
Summary
Background Several countries affected by the COVID-19 pandemic have reported a substantial drop in the number of 
patients attending the emergency department with acute coronary syndromes and a reduced number of cardiac 
procedures. We aimed to understand the scale, nature, and duration of changes to admissions for different types of 
acute coronary syndrome in England and to evaluate whether in-hospital management of patients has been affected 
as a result of the COVID-19 pandemic.
Methods We analysed data on hospital admissions in England for types of acute coronary syndrome from Jan 1, 2019, 
to May 24, 2020, that were recorded in the Secondary Uses Service Admitted Patient Care database. Admissions were 
classified as ST-elevation myocardial infarction (STEMI), non-STEMI (NSTEMI), myocardial infarction of unknown 
type, or other acute coronary syndromes (including unstable angina). We identified revascularisation procedures 
undertaken during these admissions (ie, coronary angiography without percutaneous coronary intervention [PCI], 
PCI, and coronary artery bypass graft surgery). We calculated the numbers of weekly admissions and procedures 
undertaken; percentage reductions in weekly admissions and across subgroups were also calculated, with 95% CIs.
Findings Hospital admissions for acute coronary syndrome declined from mid-February, 2020, falling from 
a 2019 baseline rate of 3017 admissions per week to 1813 per week by the end of March, 2020, a reduction of 40% 
(95% CI 37–43). This decline was partly reversed during April and May, 2020, such that by the last week of May, 2020, 
there were 2522 admissions, representing a 16% (95% CI 13–20) reduction from baseline. During the period of 
declining admissions, there were reductions in the numbers of admissions for all types of acute coronary syndrome, 
including both STEMI and NSTEMI, but relative and absolute reductions were larger for NSTEMI, with 
1267 admissions per week in 2019 and 733 per week by the end of March, 2020, a percent reduction of 42% (95% CI 
38–46). In parallel, reductions were recorded in the number of PCI procedures for patients with both STEMI (438 PCI 
procedures per week in 2019 vs 346 by the end of March, 2020; percent reduction 21%, 95% CI 12–29) and NSTEMI 
(383 PCI procedures per week in 2019 vs 240 by the end of March, 2020; percent reduction 37%, 29–45). The median 
length of stay among patients with acute coronary syndrome fell from 4 days (IQR 2–9) in 2019 to 3 days (1–5) by the 
end of March, 2020.
Interpretation Compared with the weekly average in 2019, there was a substantial reduction in the weekly numbers of 
patients with acute coronary syndrome who were admitted to hospital in England by the end of March, 2020, which 
had been partly reversed by the end of May, 2020. The reduced number of admissions during this period is likely to 
have resulted in increases in out-of-hospital deaths and long-term complications of myocardial infarction and missed 
opportunities to offer secondary prevention treatment for patients with coronary heart disease. The full extent of the 
effect of COVID-19 on the management of patients with acute coronary syndrome will continue to be assessed by 
updating these analyses.
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and the National Institute for Health Research Oxford Biomedical Research Centre.
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Introduction
Worldwide, the COVID-19 pandemic has resulted in sub-
stantial excess mortality arising directly from respiratory 
failure.1 It has necessitated major reorganisa tions of 
emergency care facilities to accommodate the additional 
workload anticipated with a rapid surge in critically ill 
patients with COVID-19.2 Cardiol ogists have reported 
substantial falls in the number of patients presenting 
with acute coronary syndromes and in the numbers of 
emergency coronary procedures in both Europe3–6 and 
the USA.7,8
The first fatality for COVID-19 in the UK was reported 
on March 5, 2020.9 On March 16, 2020, the UK Prime 
Minister urged the introduction of physical distancing 
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measures,10 and on March 23, 2020, a nationwide lockdown 
was announced.11 UK health protection regulations came 
into force on March 26, 2020,12 which severely restricted 
movement among all UK citizens, although they still 
allowed people to leave their homes for essential reasons, 
including seeking health care. Analyses by Public Health 
England show a roughly 30% reduction in emergency 
ambulance calls for chest pain in England13 and a greater 
than 52% reduction in emergency department attendances 
for myocardial ischaemia in England in March, 2020, with 
a subsequent rise.14 Furthermore, surveys of cardiologists 
in the UK and elsewhere have suggested a substantial 
reduction in demand for coronary procedures.15 On 
March 20, 2020, the British Cardiovascular Intervention 
Society issued guidance on measures to address the 
potential effect of COVID-19 on cardiology services.16
To understand the scale, nature, and duration of 
changes to admissions for different types of acute coro-
nary syndrome, and to evaluate whether in-hospital 
management of patients has been affected as a result of 
the COVID-19 pandemic, we sought data for acute coro-
nary syndrome admissions to National Health Service 
(NHS) acute hospital trusts in England from Jan 1, 2019. 
We intend to revise these analyses monthly and make 
them available online to provide an updated summary of 
changes in such admissions as the response to the 
COVID-19 pandemic evolves.
Methods
Data collection
All episodes of care for patients admitted to acute NHS 
hospital trusts in England with acute coronary syndrome, 
defined using International Classification of Diseases 
10th revision (ICD-10) codes, from Jan 1, 2019, to 
May 24, 2020, were identified in the Secondary Uses 
Service Admitted Patient Care (SUSAPC) database 
(appendix pp 2–4). We used the SUSAPC database 
because it is updated more rapidly than is the Hospital 
Episodes Statistics database. Admissions were classified 
as ST-elevation myocardial infarction (STEMI), non-
STEMI (NSTEMI), myocardial infarction of unknown 
type, or other acute coronary syndromes (including 
unstable angina), according to the recorded ICD-10 codes 
(appendix p 5).
Procedures
To prevent overcounting of acute coronary syndrome 
events, episodes of care for every individual were linked 
into continuous single hospital admissions (spells), and 
spells were linked between hospitals (superspells). 
Revascularisation procedures (ie, coronary angiography 
without percutaneous coronary intervention [PCI], PCI, 
and coronary artery bypass graft [CABG] surgery) under-
taken during these admissions were identified from 
relevant Office of Population, Censuses and Surveys 
Classification of Surgical Operations and Procedures, 
4th revision codes (appendix p 6).17 It is not possible to 
identify primary PCI in SUSAPC data, so PCI on the day 
of admission was used as a surrogate for primary PCI 
among patients with STEMI.
As a result of service reorganisation in response to 
COVID-19,16 a reduction in the speed and complete-
ness of clinical coding might have happened, which 
could result in artefactual declines in acute coronary 
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Research in context
Evidence before this study
Reports have shown reductions in admissions for acute 
coronary syndrome and in primary percutaneous coronary 
intervention (PCI) procedures for acute myocardial infarction 
during the COVID-19 pandemic in several countries (eg, Austria, 
Italy, Spain, and the USA). These studies have provided scant 
information, however, about the time course of the changes in 
admission rates, the effect on different types of acute coronary 
syndrome, the treatment of patients admitted with acute 
coronary syndrome, and the relevance of patients’ 
characteristics to the observed reductions.
Added value of this study
Our study provides quantitative information about the time 
course of admission patterns and in-hospital management for 
acute coronary syndromes, including separately for 
ST-elevation myocardial infarction (STEMI) and non-STEMI 
(NSTEMI), since January, 2019. There was a 23% (95% CI 16–30) 
reduction in admissions for STEMI, and a reduction of 
42% (38–46) in admissions for NSTEMI, from 2019 to the end 
of March, 2020. By the end of May, 2020, admission rates for 
acute coronary syndrome had partly recovered but remained 
about 16% below baseline levels. The decline in admissions 
started before the UK lockdown (which happened on 
March 23, 2020) and was qualitatively similar throughout the 
country, with only minor variations in the magnitude of the 
changes in different demographic groups. Our study also 
identified changes in the management of patients who were 
admitted with an acute myocardial infarction throughout this 
period, with both a sustained increase in the proportion of 
patients receiving PCI on the day of admission and a continued 
reduction in the median length of stay.
Implications of all the available evidence
Patients who do not go to hospital with an acute coronary 
syndrome, particularly STEMI, cannot benefit from reperfusion 
therapy or other appropriate treatments and are at increased 
risk of complications. The reasons for patients failing to attend 
emergency departments with acute coronary syndrome and 
other urgent conditions should be addressed promptly to 
avoid unnecessary deaths and disability, particularly during 
subsequent recurrences of COVID-19 in the UK or elsewhere.
See Online for appendix
For updated analyses see 
https://www.ctsu.ox.ac.uk/
research/covid-19-acute-
coronary-syndromes
For ICD-10 codes see https://icd.
who.int/browse10/2019/en
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syndrome-related admissions (particularly in the most 
recent data). For each week after Feb 17, 2020, we 
investigated this possibility by ascertaining the propor-
tion of all SUSAPC records recorded in each week that 
contained no diagnostic ICD-10 codes, and an adjustment 
was made to the numbers of recorded admissions for 
acute coronary syndrome each week based on these 
proportions.
Statistical analysis
In all analyses of admission numbers, data are presented 
for 2019 as median (IQR) weekly recorded numbers. 
For 2020, a local polynomial regression smoothing 
function (locally estimated scatterplot smoothing) was 
fitted through the weekly numbers (using the loess 
function in R with default settings). From 2020, weekly 
adjusted numbers (indicating the number of admissions 
in the preceding 7 days) are plotted along with their 
approximate SEs (under the assumption that the 
numbers follow a Poisson distribution). Percentage 
changes in weekly admissions were calculated by 
comparing the adjusted weekly admission number for 
the week commencing March 23, 2020, the week in 
which the lowest number of admissions was observed, 
with the mean weekly number during 2019; percentage 
changes are presented with 95% CIs. Percent age changes 
in weekly admissions among subgroups were calculated 
similarly, with tests for heterogeneity or trend across 
every subgroup presented. Monthly updates of tables and 
figures are available online. Analyses were produced 
using R version 3.6.3.
Role of the funding source
The funders had no role in study design, data collection, 
data analysis, data interpretation, or writing of the report. 
The corresponding author had full access to all data in 
For more on R software see 
https://r-project.org
Monthly average for 
2019 (n=13 075)
January, 2020 
(n=13 645)
February, 2020 
(n=12 443)
March, 2020 
(n=10 118)
April, 2020 
(n=8739)
May, 2020 
(n=9756)
Sex
Female 4829 (37%) 5131 (38%) 4518 (36%) 3670 (36%) 3038 (35%) 3301 (34%)
Male 8245 (63%) 8513 (62%) 7921 (64%) 6441 (64%) 5652 (65%) 6404 (66%)
Age group
<50 years 953 (7%) 1051 (8%) 953 (8%) 754 (7%) 713 (8%) 799 (8%)
50–59 years 2082 (16%) 2156 (16%) 2013 (16%) 1686 (17%) 1516 (17%) 1760 (18%)
60–69 years 2723 (21%) 2821 (21%) 2553 (21%) 2203 (22%) 1931 (22%) 2136 (22%)
70–79 years 3353 (26%) 3556 (26%) 3184 (26%) 2558 (25%) 2171 (25%) 2456 (25%)
≥80 years 3963 (30%) 4061 (30%) 3740 (30%) 2917 (29%) 2408 (28%) 2605 (27%)
Ethnic group
White 10 313 (79%) 10 678 (78%) 9744 (78%) 7865 (78%) 6872 (79%) 7565 (78%)
Mixed race 58 (<1%) 65 (<1%) 71 (1%) 43 (<1%) 31 (<1%) 31 (<1%)
Asian 956 (7%) 998 (7%) 887 (7%) 677 (7%) 510 (6%) 616 (6%)
Black 196 (2%) 204 (1%) 177 (1%) 149 (1%) 138 (2%) 123 (1%)
Other or unknown 1552 (12%) 1700 (12%) 1564 (13%) 1384 (14%) 1180 (14%) 1421 (15%)
Charlson index
0 3933 (30%) 4032 (30%) 3639 (29%) 3128 (31%) 2764 (32%) 3240 (33%)
1 3591 (27%) 3712 (27%) 3482 (28%) 2899 (29%) 2449 (28%) 2697 (28%)
2 2180 (17%) 2340 (17%) 2140 (17%) 1676 (17%) 1405 (16%) 1572 (16%)
3+ 3371 (26%) 3561 (26%) 3182 (26%) 2415 (24%) 2121 (24%) 2247 (23%)
Region of admission*
Northeast 705 (5%) 700 (5%) 690 (6%) 550 (5%) 460 (5%) 505 (5%)
Northwest 2050 (16%) 2200 (16%) 1920 (15%) 1625 (16%) 1495 (17%) 1550 (16%)
Yorkshire and Humber 1510 (12%) 1635 (12%) 1435 (12%) 1245 (12%) 1040 (12%) 1180 (12%)
East Midlands 1060 (8%) 1115 (8%) 1010 (8%) 825 (8%) 655 (7%) 800 (8%)
West Midlands 1380 (11%) 1395 (10%) 1285 (10%) 1040 (10%) 890 (10%) 1080 (11%)
East of England 1380 (11%) 1400 (10%) 1380 (11%) 1035 (10%) 960 (11%) 980 (10%)
London 1720 (13%) 1805 (13%) 1645 (13%) 1260 (12%) 1060 (12%) 1225 (13%)
Southeast 1750 (13%) 1860 (14%) 1690 (14%) 1410 (14%) 1235 (14%) 1415 (15%)
Southwest 1520 (12%) 1535 (11%) 1385 (11%) 1135 (11%) 945 (11%) 1020 (10%)
Data are n (%). Numbers of admissions are unadjusted for incomplete coding (appendix pp 2–4). Percentage changes in admission rates for each subgroup are provided in 
the appendix (p 7). *Regional numbers are rounded to the nearest multiple of 5.
Table 1: Characteristics of patients admitted to acute National Health Service hospital trusts in England with a diagnosis of any acute coronary syndrome 
(January, 2019, to May, 2020)
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the study and had final responsibility for the decision to 
submit for publication.
Results
SUSAPC data were available from all 147 acute NHS 
hospital trusts in England. Demographic characteristics 
of patients with acute coronary syndrome during January 
to May, 2020, were similar to the monthly average 
for 2019 (table 1). In 2019, the average number of 
acute coronary syndrome admissions per week from 
February to April, 2019 (3082 per week), was similar to 
the average number during the other months of the year 
(2994 per week).
A decline was seen in hospital admissions for acute 
coronary syndrome between mid-February, 2020, and the 
end of March, 2020 (figure 1), with the 2019 baseline 
number of 3017 admissions per week falling to 1813 per 
week (proportional reduction 40%, 95% CI 37–43; table 2). 
This decline was partly reversed during April and 
May, 2020, such that by the last week of May, 2020, there 
were 2522 admissions, representing a 16% (95% CI 13–20) 
reduction from baseline (figure 1). Reductions were 
recorded in numbers of admissions for acute myocardial 
infarction, STEMI, and NSTEMI from the average 
for 2019, to the end of March, 2020 (figure 1; table 2). The 
percentage reduction in admissions for all acute myo-
cardial infarctions was 35% (95% CI 32–39), with an 
average of 2061 admissions per week in 2019, falling to 
1335 per week by the end of March, 2020. For STEMI, 
there were 621 admissions per week in 2019 and 477 per 
week by the end of March, 2020 (percentage reduction 
in admissions 23%, 95% CI 16–30). The percentage 
reduction in admissions for NSTEMI was 42% (95% CI 
38–46), with 1267 admissions per week in 2019 and 
733 per week by the end of March, 2020. Admissions for 
both STEMI and NSTEMI rose through April and 
May, 2020, such that, by the last week of May, 2020, 
admissions were 10% lower than the 2019 baseline for 
STEMI (95% CI 2–17; 561 admissions per week) and 
24% lower for NSTEMI (95% CI 19–28; 966 admissions 
per week; figure 1).
The 23% reduction in admissions for STEMI was 
accompanied by a slight rise in the proportion of patients 
admitted to hospital and receiving PCI on the day of 
admission (figure 2). As a result, the absolute number 
of patients with STEMI receiving PCI on the day of 
admission fell between 2019 and the end of March, 2020 
(from 379 per week to 309 per week), a proportional 
reduction of 18% (95% CI 9–27; table 2; figure 3). The 
42% reduction in NSTEMI admissions was accompanied 
by a slight increase in the proportion who received PCI 
at any time during admission (table 2; appendix p 8), 
which translated into a percentage reduction of 37% 
(95% CI 29–45) and a decrease in absolute numbers 
receiving PCI from 383 per week in 2019 to 240 per 
week by the end of March, 2020. For all types of acute 
coronary syndrome combined, the percentage reduc-
tion in patients having angiography without PCI was 
60% (95% CI 53–65), with 429 procedures per week 
in 2019 and 172 per week by the end of March, 2020. 
CABG surgery during admission had largely ceased 
by April, 2020 (figure 3), with a percentage reduction of 
80% (95% CI 68–87; table 2).
By the end of March, 2020, the median length of stay 
among patients admitted with any acute coronary 
syndrome fell from 4 days (IQR 2–9) in 2019 to 3 days 
(1–5; appendix p 9). For STEMI, the reduction in median 
stay was from 3 days (IQR 2–6) to 2 days (2–4) and 
for NSTEMI it was from 5 days (3–11) to 3 days (2–6). 
The length of stay remained lower during April and 
May, 2020. There was no apparent change in in-hospital 
mortality among patients admitted with acute coronary 
syndrome (data not shown).
The relative reductions in weekly numbers of 
admissions for acute coronary syndrome by the end of 
March, 2020, were qualitatively similar in all of the 
subgroups studied, but they seemed slightly larger 
Figure 1: Weekly admissions to acute National Health Service hospital trusts in England with an acute 
coronary syndrome, by type
For weekly admissions in 2019, boxplots show the median and IQR, with whiskers extending (up to) 1·5 times the 
IQR above the upper quartile and below the lower quartile, with any weekly counts beyond those ranges indicated 
by x. For 2020, a locally estimated scatterplot smoothing spline is fitted through the weekly reported counts, 
with datapoints and SEs plotted. The date of the UK COVID-19 lockdown (March 23, 2020) is shown with a vertical 
dotted line. STEMI=ST-elevation myocardial infarction. NSTEMI=non-ST-elevation myocardial infarction.
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among patients with a higher (worse) Charlson comor-
bidity index and for individuals in the London and 
East Midlands regions of England (appendix pp 7, 10).
Discussion
Previous reports of reduced admissions for acute coronary 
syndrome and decreased use of coronary procedures in 
various countries affected by the COVID-19 pandemic3–8 
have indicated that declines in admissions and procedures 
are widespread. However, those reports have provided 
scant detail: in particular, only one study8 reported the 
time course of changes in number of admissions, and 
there has been a paucity of information about the relative 
effect on different types of acute coronary syndrome, 
the acute management of patients admitted with acute 
coronary syndrome, and the relevance of patients’ 
characteristics. By contrast, in our study, unique access to 
rapidly available, central NHS health-care data has 
allowed us to produce near real-time analyses based on all 
admissions for acute coronary syndrome in all 147 acute 
hospitals across England. Moreover, we are able to follow 
emerging trends over time as the response to COVID-19 
evolves (eg, with easing of restrictions and any recurrent 
outbreaks of infection).
Our study provides several key insights into the noted 
reduction in admissions for acute coronary syndrome. 
First, by the end of March, 2020, the average weekly 
number of acute coronary syndrome admissions fell 
by 40% compared with the average weekly number 
observed during 2019. The decline seems to have 
started at least 2 weeks before the first UK death from 
COVID-19 (on March 5, 2020), and about a month 
before the UK Government implemented the lockdown 
(on March 23, 2020). This finding is consistent with a 
report based on data from US Kaiser Permanente 
Northern California, which indicated that the reduction 
in acute myocardial infarction admissions preceded the 
US shelter-in-place order by about 2 weeks.8 Our study 
also shows that, beginning in April, 2020, admissions 
for acute coronary syndrome in England began to 
return to normal and, by the end of May, 2020, were 
about 16% below the 2019 baseline level. Measured 
against this baseline, from January, 2020, until the 
end of May, 2020, there had been around 8000 fewer 
admissions for acute coronary syndromes than would 
be expected, including 5000 fewer admissions for 
myocardial infarction, and this deficit will continue 
to grow until weekly admission numbers return to 
normal.
By mid-February, 2020, UK media were reporting the 
spread of severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2) in China and in northern Italy. NHS 
hospitals had been told to prepare for a large influx of 
patients with COVID-19. As early as Feb 14, 2020, fear-
inducing language was noted in the media.18 Taken 
together with survey data from Hong Kong, in which 
patients delayed seeking medical help because of worries 
about acquiring COVID-19,19 it seems likely that fear of 
contagion has been a major factor underlying the 
observed reduction in admissions for acute coronary 
syndrome in our study. The partial recovery in admission 
rates by the end of May, 2020, suggests that the British 
Heart Foundation and British Cardiovascular Society 
publicity campaign in early April, 2020, in which people 
All admissions Any PCI PCI on day of 
admission
PCI after day of 
admission
CABG surgery Angiography only
Acute coronary syndrome
2019 weekly average 3017 909 464 450 93 429
March 23–30, 2020 1813 631 392 239 19 172
Percent reduction (95% CI) 40% (37 to 43) 31% (25 to 36) 16% (7 to 24) 47% (40 to 53) 80% (68 to 87) 60% (53 to 65)
Acute myocardial infarction
2019 weekly average 2061 834 453 386 80 306
March 23–30, 2020 1335 594 381 213 17 139
Percent reduction (95% CI) 35% (32 to 39) 29% (23 to 34) 16% (7 to 24) 45% (37 to 52) 79% (66 to 87) 55% (46 to 62)
STEMI
2019 weekly average 621 438 379 63 16 49
March 23–30, 2020 477 346 309 36 4 34
Percent reduction (95% CI) 23% (16 to 30) 21% (12 to 29) 18% (9 to 27) 43% (21 to 59) 75% (33 to 91) 31% (3 to 51)
NSTEMI
2019 weekly average 1267 383 67 317 63 245
March 23–30, 2020 733 240 68 172 13 97
Percent reduction (95% CI) 42% (38 to 46) 37% (29 to 45) –1% (–29 to 20) 46% (37 to 53) 79% (64 to 88) 60% (52 to 68)
Data are n per week, unless otherwise stated. PCI=percutaneous coronary intervention. CABG=coronary artery bypass graft. STEMI=ST-elevation myocardial infarction. 
NSTEMI=non-ST-elevation myocardial infarction.
Table 2: Percent reduction in weekly acute coronary syndrome admissions to acute National Health Service hospital trusts in England, from average 
weekly admissions in 2019 to admissions week commencing March 23, 2020, the week in which the lowest number of admissions was observed
Articles
386 www.thelancet.com   Vol 396   August 8, 2020
with heart attack symptoms were encouraged to attend 
hospital, could have helped to allay such fears.20 The 
observation that the decline in admissions preceded 
the UK lockdown and, despite the continuing lockdown, 
had partly recov ered by the end of May, 2020, suggests 
that envi ron mental changes (eg, reduced air pollution), 
decreased physical activity, or diminished stress because 
of lock down are unlikely to be major contributors to the 
noted trends in acute coronary syndrome admissions in 
the current pandemic.21,22
A second novel finding of our analysis is the clear 
distinction between the 23% reduction in STEMI admis-
sions compared with the 42% reduction of NSTEMI 
admissions. Our analyses in an unselected study popu-
lation are based on much larger numbers of admissions 
than in any previous study, some of which reported a 
smaller reduction for STEMI than for NSTEMI (in Italy),5 
whereas studies in Austria and northern California did 
not detect a difference in decreases for different types of 
myocardial infarction.3,8 As STEMI is generally associated 
with severe and unremitting symptoms, patients with 
STEMI could be less reluctant to seek help irrespective of 
any fears they might have about attending a hospital, 
whereas those with NSTEMI might be able to tolerate 
less severe symptoms and so opt to remain at home.
Third, we were able to document how acute manage-
ment of admitted patients changed during the pandemic 
period. In preparation for the COVID-19 pandemic, UK 
cardiology services were reorganised such that elective 
PCI and CABG surgery would not be available routinely 
during the outbreak. Instead, it was recommended that, 
if current NSTEMI pathways could not be followed 
because of reduced intensive care unit capacity or other 
issues, PCI should be used in place of surgery and 
inpatient stays reduced to 36–48 h.16 Consistent with 
these recommendations, our results show that patients 
admitted with NSTEMI were more likely to receive PCI 
while in hospital (often on the day of admission) and to 
Weekly number of admitted patients receiving PCI on the day of admission
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Figure 2: Weekly admissions to acute National Health Service hospital trusts in England with an acute coronary syndrome receiving PCI on the day of 
admission
For weekly admissions in 2019, boxplots show the median and IQR, with whiskers extending (up to) 1·5 times the IQR above the upper quartile and below the lower 
quartile, with any weekly counts beyond those ranges indicated by x. For 2020, a locally estimated scatterplot smoothing spline is fitted through the weekly reported 
counts or proportions. Vertical lines represent 1 SD for weekly counts or proportions. The date of the UK COVID-19 lockdown (March 23, 2020) is shown with a 
vertical dotted line. STEMI=ST-elevation myocardial infarction. NSTEMI=non-ST-elevation myocardial infarction. PCI=percutaneous coronary intervention. 
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have shorter hospital stays. However, since the numbers 
of patients admitted with both NSTEMI and STEMI were 
reduced, fewer patients with acute coronary syndrome 
received PCI.
Finally, the large numbers of cases and national 
coverage of these data allowed us to show that the pattern 
of reduced admissions was qualitatively similar (albeit 
slightly different quantitatively) in several important 
demographic groups. For example, despite the greater 
risk with COVID-19 among older patients and those 
with comorbidities, there were similar reductions in the 
numbers of individuals with acute coronary syndrome 
admitted at younger ages and without comorbidities, in 
whom the long-term benefits of cardiovascular inter-
ventions would typically be greater. Likewise, despite 
different COVID-19 admission rates across the UK 
during the early phase of the pandemic, little difference 
was seen in the reduction in acute coronary syndrome 
admissions between different regions. This consistency 
suggests that drivers of the noted fall in admissions are 
likely to be common (to a greater or lesser extent) to all 
patient groups.
Taken together, the substantial reduction in admissions 
for acute coronary syndrome during the COVID-19 
pandemic is a serious concern, because patients with 
symptoms indicative of acute myocardial ischaemia 
benefit from rapid in-hospital assessment,23,24 with the 
gain being greatest among those with STEMI. Among 
such patients, there is a substantial risk of out-of-hospital 
cardiac arrest,25 and the failure of patients with STEMI to 
be admitted to hospital so they can receive early reper-
fusion therapy and other appropriate treatments is likely 
to have resulted in avoidable deaths and complications, 
such as fatal arrhythmias26 and disabling heart failure.27 
Although no overall increase in in-hospital mortality 
was seen among patients admitted for acute coronary 
syndrome, a direct comparison between mortality rates 
before and after mid-March, 2020, is likely to be con-
founded by differences in underlying risk of admitted 
patients and by the duration of hospital stay. Moreover, it 
is not possible to assess directly the deaths and disability 
that probably occurred among those patients with acute 
coronary syndrome who were not admitted to hospital 
because of COVID-19 and, therefore, did not receive 
treatment that is known to be effective.
What are the implications of our findings for the UK 
and for other countries, including settings where the 
COVID-19 pandemic is only just starting, and how can 
they help inform preparations for any subsequent 
increases in infection rates now that lockdown restric-
tions are being relaxed? Our findings confirm the general 
pattern reported from other countries. Furthermore, the 
quali tative similarity of decreases in acute coronary 
syndrome admission rates, irrespective of age, sex, 
number of comorbidities, and region, suggests that our 
findings are likely to be generalisable to all patients who 
are having an acute myocardial infarction, not only in 
the UK but also elsewhere in the world. If the reduction 
in hospital admissions is largely or wholly because of fear 
of exposure to SARS-CoV-2, it seems probable that the 
same reduction in admissions will be seen wherever 
there is a rapid increase in COVID-19 cases and public 
health messaging is not suitably nuanced. Monthly 
updates of these analyses will continue to monitor the 
recovery in acute coronary syndrome admissions and 
provide an early warning of another decline in admission 
trends during any subsequent recurrence of COVID-19 in 
the UK. More generally, it would be valuable to establish 
similar continuous analyses for other serious diseases in 
the UK and in other locations where centralised electronic 
health record data are available (eg, China or Sweden, or 
in US health mainte nance organisations), to monitor 
such trends to ensure that they reverse and do not recur 
during this pandemic or, indeed, any subsequent ones.
Figure 3: Weekly admissions to acute National Health Service hospital trusts in England with an acute 
coronary syndrome receiving a coronary procedure
For weekly admissions in 2019, boxplots (coloured according to type of procedure) show the median and IQR, 
with whiskers extending (up to) 1·5 times the IQR above the upper quartile and below the lower quartile, with any 
weekly counts beyond those ranges indicated by x. For 2020, a locally estimated scatterplot smoothing spline is 
fitted through the weekly reported counts, with datapoints and SEs plotted. The date of the UK COVID-19 lockdown 
(March 23, 2020) is shown with a vertical dotted line. CABG=coronary artery bypass graft. STEMI=ST-elevation 
myocardial infarction. NSTEMI=non-ST-elevation myocardial infarction. PCI=percutaneous coronary intervention. 
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